Wells Fargo
RKDA icon

Wells Fargo’s Arcadia Biosciences RKDA Stock Holding History

Wells Fargo’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9
Closed -$20 – 7366
2024
Q1 		$20 Hold
9
– – ﹤0.01% 7118
2023
Q4 		$28 Buy
9
+1
+13% +$3 ﹤0.01% 7102
2023
Q3 		$27 Buy
8
+2
+33% +$8 ﹤0.01% 7108
2023
Q2 		$23 Sell
6
-573
-99% -$3.05K ﹤0.01% 7274
2023
Q1 		$4.33K Hold
579
– – ﹤0.01% 6086
2022
Q4 		$6.28K Sell
579
-474
-45% -$6.75K ﹤0.01% 5707
2022
Q3 		$22K Sell
1,053
-50
-5% -$1.71K ﹤0.01% 5350
2022
Q2 		$44K Buy
1,103
+161
+17% +$7.41K ﹤0.01% 5087
2022
Q1 		$53K Buy
942
+213
+29% +$10.2K ﹤0.01% 5627
2021
Q4 		$30K Sell
729
-711
-49% -$46.4K ﹤0.01% 6195
2021
Q3 		$119K Buy
1,440
+311
+28% +$29.2K ﹤0.01% 5320
2021
Q2 		$134K Buy
1,129
+200
+22% +$21.8K ﹤0.01% 5181
2021
Q1 		$102K Buy
929
+152
+20% +$18.6K ﹤0.01% 5475
2020
Q4 		$78K Buy
777
+293
+61% +$35.8K ﹤0.01% 5446
2020
Q3 		$54K Buy
484
+65
+16% +$8.78K ﹤0.01% 5479
2020
Q2 		$63K Buy
419
+10
+2% +$1.55K ﹤0.01% 5418
2020
Q1 		$46K Buy
409
+296
+262% +$51.5K ﹤0.01% 5370
2019
Q4 		$25K Buy
113
+50
+79% +$10K ﹤0.01% 5694
2019
Q3 		$12K Hold
63
– – ﹤0.01% 5908
2019
Q2 		$8K Buy
+63
New +$13.4K ﹤0.01% 5960
2018
Q4 		– Sell
-544
Closed -$106K – 6578
2018
Q3 		$106K Buy
544
+163
+43% +$40.9K ﹤0.01% 5335
2018
Q2 		$126K Buy
381
+308
+422% +$168K ﹤0.01% 5270
2018
Q1 		$70K Buy
+73
New +$32.8K ﹤0.01% 5451
2017
Q1 		– Sell
-3
Closed -$2K – 6466
2016
Q4 		$2K Hold
3
– – ﹤0.01% 6101
2016
Q3 		$4K Hold
3
– – ﹤0.01% 5958
2016
Q2 		$5K Buy
3
+2
+200% +$3.35K ﹤0.01% 5817
2016
Q1 		$3K Hold
1
– – ﹤0.01% 5971
2015
Q4 		$2K Buy
+1
New +$2.6K ﹤0.01% 6020
2015
Q3 		– Sell
-26
Closed -$108K – 6401
2015
Q2 		$131K Buy
+26
New +$162K ﹤0.01% 4864

Other funds holding RKDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Wells Fargo's RKDA Position: Q2 2024 in Review

Wells Fargo sold out of Arcadia Biosciences (RKDA) in Q2 2024, closing a stake of 9 shares — an estimated $20 sold.

Wells Fargo first reported a position in RKDA in Q2 2015 and held it in 29 quarters. The position peaked at $134K in Q2 2021. 11 funds tracked by Wall St. Rank hold RKDA as of Q2 2024.

  • Wells Fargo reported no remaining Arcadia Biosciences position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 9 Arcadia Biosciences shares in Q2 2024, an estimated $20.
  • Wells Fargo first reported a position in Arcadia Biosciences in Q2 2015 and held it in 29 quarters.
  • Wells Fargo's Arcadia Biosciences position peaked at $134K in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.